These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1384960)
21. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters. Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715 [TBL] [Abstract][Full Text] [Related]
22. Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study. Hayes DF; Mesa-Tejada R; Papsidero LD; Croghan GA; Korzun AH; Norton L; Wood W; Strauchen JA; Grimes M; Weiss RB J Clin Oncol; 1991 Jul; 9(7):1113-23. PubMed ID: 2045853 [TBL] [Abstract][Full Text] [Related]
23. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions. Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527 [TBL] [Abstract][Full Text] [Related]
24. Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells. Guilbaud NF; Gas N; Dupont MA; Valette A J Cell Physiol; 1990 Oct; 145(1):162-72. PubMed ID: 2211839 [TBL] [Abstract][Full Text] [Related]
25. Effect of radioiodination on the binding of monoclonal antibody DF3 to breast carcinoma cells. Hayes DF; Noska MA; Kufe DW; Zalutsky MR Int J Rad Appl Instrum B; 1988; 15(3):235-41. PubMed ID: 2454899 [TBL] [Abstract][Full Text] [Related]
26. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate. Ohannesian DW; Lotan D; Lotan R Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433 [TBL] [Abstract][Full Text] [Related]
27. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid. Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585 [TBL] [Abstract][Full Text] [Related]
28. Surface expression of tumor-associated antigens in primary cultured human colonic epithelial cells from carcinomas, benign tumors, and normal tissues. Friedman E; Thor A; Hand PH; Schlom J Cancer Res; 1985 Nov; 45(11 Pt 2):5648-55. PubMed ID: 2413994 [TBL] [Abstract][Full Text] [Related]
29. Detection and characterization of a high molecular weight human lung carcinoma-associated glycoprotein. Maimonis P; Hayes DF; O'Hara C; Kufe D Cancer Res; 1990 Oct; 50(20):6738-43. PubMed ID: 1698541 [TBL] [Abstract][Full Text] [Related]
30. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast. Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774 [TBL] [Abstract][Full Text] [Related]
31. Genetically determined polymorphism of the circulating human breast cancer-associated DF3 antigen. Hayes DF; Sekine H; Marcus D; Alper CA; Kufe DW Blood; 1988 Feb; 71(2):436-40. PubMed ID: 3337905 [TBL] [Abstract][Full Text] [Related]
32. Modulation of human tumor antigen expression. Greiner JW; Hand PH; Colcher D; Weeks M; Thor A; Noguchi P; Pestka S; Schlom J J Lab Clin Med; 1987 Mar; 109(3):244-61. PubMed ID: 2434589 [TBL] [Abstract][Full Text] [Related]
33. CA19-9 epitope a possible marker for MUC-1/Y protein. Akagi J; Takai E; Tamori Y; Nakagawa K; Ogawa M Int J Oncol; 2001 May; 18(5):1085-91. PubMed ID: 11295060 [TBL] [Abstract][Full Text] [Related]
34. K562 erythroleukemia cells express cytokeratins 8, 18, and 19 and epithelial membrane antigen that disappear after induced differentiation. Järvinen M; Andersson LC; Virtanen I J Cell Physiol; 1990 May; 143(2):310-20. PubMed ID: 1692028 [TBL] [Abstract][Full Text] [Related]
35. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture. Johnston WW Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301 [TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells. Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251 [TBL] [Abstract][Full Text] [Related]
37. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Hull SR; Bright A; Carraway KL; Abe M; Hayes DF; Kufe DW Cancer Commun; 1989; 1(4):261-7. PubMed ID: 2639730 [TBL] [Abstract][Full Text] [Related]
38. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612. Fernsten PD; Primus FJ; Greiner JW; Simpson JF; Schlom J Cancer Res; 1991 Feb; 51(3):926-34. PubMed ID: 1988133 [TBL] [Abstract][Full Text] [Related]
39. Expression of tumour associated antigens 12H12, 2E11, 7A9, CEA and DF3 in human breast cancer. Eskelinen M; Lipponen P; Hippeläinen M; Seveus L; Syrajänen K Anticancer Res; 1993; 13(6B):2399-406. PubMed ID: 8135473 [TBL] [Abstract][Full Text] [Related]
40. Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells. Velcich A; Palumbo L; Jarry A; Laboisse C; Racevskis J; Augenlicht L Cell Growth Differ; 1995 Jun; 6(6):749-57. PubMed ID: 7669730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]